PT1.03.06 Mechanisms of Acquired Resistance to First-Line Amivantamab Plus Lazertinib Vs Osimertinib: Updated Analysis from MARIPOSA

作者：Hidetoshi Hayashi, Benjamin Besse, SH Lee, Lu Shen, Duc Nguyen, Sanjay Popat, James Chih‐Hsin Yang, Maya Gottfried, Josiane Mourão Dias, Claire Martin, Mehmet Alı Nahıt Şendur, L. Paz-Ares, Scott Owen, Maria Campelo, Bo Wang, Sean K. Sethi, Shalin Shah, Jing Zhang, Joshua C. Curtin, B.C. Cho · 发表于：Journal of Thoracic Oncology · 年份：2025 · DOI：10.1016/j.jtho.2025.09.1118 · 被引用次数：5 · 研究领域：Lung Cancer Treatments and Mutations、Chronic Myeloid Leukemia Treatments、PI3K/AKT/mTOR signaling in cancer